Synergix Ltd.
Biotechnology - , ,
Synergix Ltd. Employees
Synergix Ltd. Details
Synergix creates new lead prototype molecules with proven biological activities for pharmaceutical companies. Synergix has pioneered 'rational drug design' computerized technologies that positions the company at the forefront of innovation in the drug discovery area.Synergix draws upon a vast resource of expertise available through its founder and a worldwide scientific network in the fields of chemistry, biology, pharmacology, and medicine.Synergix was founded in 1996 by Dr. Claude Cohen, a pioneer of Rational Drug Design. He developed and applied this approach to active molecule design whileemployed first by Hoechst-Roussel-Uclaf-Marion in France (now Aventis) and later by Ciba-Geigy in Switzerland (now Novartis). At Ciba-Geigy he created and managed one of the largest and most competitive drug design groups in the world. Dr. Cohen's group contributed to the discovery of eight drugs currently in development. These drugs were discovered using the technology he developed, one of them (Diovan/Valsartan) was introduced to the market in December 1996, with sales of up to $ 2 billion - in 2003.
